The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 1, 2006, Pages 49-56

  Ayhan, Ali ^a   Gultekin, Murat ^a   Taskiran, Cagatay ^a   Aksan, Guldeniz ^a   Celik, Nilufer Yigit ^a   Dursun, Polat ^a   Salman, M Coskun ^a   Yuce, Kunter ^a   Kucukali, Turkan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Epithelial ovarian carcinoma; Optimal debulking; Recurrent ovarian carcinoma; Secondary cytoreduction

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CONFIDENCE INTERVAL; CYTOREDUCTIVE SURGERY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 29544448985     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.06.048     Document Type: Article

References (25)

1. A.R. Munkarah, and R.L. Coleman Critical evaluation of secondary cytoreduction in recurrent ovarian cancer Gynecol Oncol 95 2004 273 280
2. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, and K.Y. Look Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1996 1 6
3. L.M. Chen, and B.Y. Karlan Recurrent ovarian carcinoma: is there a place for surgery? Semin Surg Oncol 19 2000 62 68
4. F. Parazzini, F. Raspagliesi, P. Guarnerio, and G. Bolis Role of secondary surgery in relapsed ovarian cancer Crit Rev Oncol Hematol 37 2001 121 125
5. P.G. Rose Surgery for recurrent ovarian cancer Semin Oncol 27 Suppl 7 2000 17 23
6. A.E. Selman, and L.J. Copeland Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial Crit Rev Oncol Hematol 41 2002 335 341
7. S.M. Eisenkop, R.L. Friedman, and H.J. Wang Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study Cancer 76 1995 1606 1614
8. S.M. Eisenkop, R.L. Friedman, and N.M. Spirtos The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma Cancer 88 2000 144 153
9. A. Gadducci, P. Iacconi, S. Cosio, A. Fanucchi, R. Cristofani, and A.R. Genazzani Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer Gynecol Oncol 79 2000 344 349
10. R.A. Segna, P.R. Dottino, J.P. Mandeli, K. Konsker, and C.J. Cohen Secondary cytoreduction for ovarian cancer following cisplatin therapy J Clin Oncol 11 1993 434 439
11. C. Scarabelli, A. Gallo, and A. Carbone Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 83 2001 504 512
12. R.Y. Zang, Z.T. Li, J. Tang, X. Cheng, S.M. Cai, and Z.Y. Zhang Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 100 2004 1152 1161
13. J.S. Berek, N.F. Hacker, L.D. Lagasse, R.K. Nieberg, and R.M. Elashoff Survival of patients following secondary cytoreductive surgery in ovarian cancer Obstet Gynecol 61 1983 189 193
14. F. Janicke, M. Holscher, W. Kuhn, R. von Hugo, L. Pache, and J.R. Siewert Radical surgical procedure improves survival time in patients with recurrent ovarian cancer Cancer 70 1992 2129 2136
15. E.H. Tay, P.T. Grant, V. Gebski, and N.F. Hacker Secondary cytoreductive surgery for recurrent epithelial ovarian cancer Obstet Gynecol 99 2002 1008 1013
16. R.Y. Zang, Z.Y. Zhang, Z.T. Li, J. Chen, M.Q. Tang, and Q. Liu Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer J Surg Oncol 75 2000 24 30
17. R.Y. Zang, Z.Y. Zhang, Z.T. Li, S.M. Cai, M.Q. Tang, and J. Chen Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer Eur J Surg Oncol 26 2000 798 804
18. R.Y. Zang, Z.T. Li, Z.Y. Zhang, and S.M. Cai Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study Int J Gynecol Cancer 13 2003 419 427
19. A. Munkarah, C. Levenback, J.K. Wolf, D. Bodurka-Bevers, G. Tortolero-Luna, and R.T. Morris Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer Gynecol Oncol 81 2001 237 241
20. M. Morris, D.M. Gershenson, J.T. Wharton, L.J. Copeland, C.L. Edwards, and C.A. Stringer Secondary cytoreductive surgery for recurrent epithelial ovarian cancer Gynecol Oncol 34 1989 334 338
21. L. Vaccarello, S.C. Rubin, V. Vlamis, G. Wong, W.B. Jones, and J.L. Lewis Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response Gynecol Oncol 57 1995 61 65
22. B. Gronlund, L. Lundvall, I.J. Christensen, J.B. Knudsen, and C. Hogdall Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum Eur J Surg Oncol 31 2005 67 73
23. M. Güngör, F. Ortaç, M. Arvas, D. Kösebay, M. Sönmezer, and K. Köse The role of secondary cytoreductive surgery for recurrent ovarian cancer Gynecol Oncol 97 2005 74 79
24. W.J. Hoskins, S.C. Rubin, E. Dulaney, D. Chapman, L. Almadrones, and P. Saigo Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma Gynecol Oncol 34 1989 365 371
25. K.C. Podratz, M.F. Schray, H.S. Wieand, J.H. Edmonson, J.A. Jefferies, and H.J. Long Evaluation of treatment and survival after positive second-look laparotomy Gynecol Oncol 31 1988 9 24